← Back to Analyst Consensus 
MLYS Buy
Mineralys Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 1 reiterations from 2 firms
Next Earnings
Nov 16, 2026 (21 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | UBS | initiate | — → Neutral | — | 54% |
| Oct 12, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 27, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| Mar 13, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Dec 19, 2025 | Stifel | maintain | Buy → Buy | $52 | 53% |
| Nov 12, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $56 | 44% |
| Nov 11, 2025 | Wells Fargo | maintain | Overweight → Overweight | $55 | 54% |
| Oct 30, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $52 | 44% |
| Sep 11, 2025 | Wells Fargo | maintain | Overweight → Overweight | $50 | 54% |
| Sep 9, 2025 | Goldman Sachs | maintain | Buy → Buy | $52 | 54% |
| Sep 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $42 | 44% |
| Sep 3, 2025 | Jefferies | maintain | Hold → Hold | $26 | 52% |
| Aug 28, 2025 | B of A Securities | maintain | Buy → Buy | $43 | 53% |
| Aug 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $42 | 44% |
| Jun 17, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $42 | 44% |
| Jun 11, 2025 | Jefferies | initiate | — → Hold | $15 | 52% |
| May 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $42 | 44% |
| Apr 2, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $42 | 44% |
| Mar 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Feb 24, 2025 | Guggenheim | reiterate | Buy → Buy | $0 | 52% |
| Feb 13, 2025 | Goldman Sachs | maintain | Buy → Buy | $24 | 54% |
| Feb 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Nov 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Oct 31, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Aug 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Jul 10, 2024 | HC Wainwright & Co. | initiate | — → Buy | $30 | 44% |
| Apr 2, 2024 | Goldman Sachs | initiate | — → Buy | $30 | 54% |
| Aug 8, 2023 | Credit Suisse | maintain | Outperform → Outperform | $37 | — |
| May 16, 2023 | Credit Suisse | reiterate | Outperform → Outperform | $38 | — |
| Mar 16, 2023 | Credit Suisse | maintain | — → Outperform | $38 | — |
| Mar 7, 2023 | Evercore ISI Group | initiate | — → Outperform | $0 | 58% |
| Mar 7, 2023 | Wells Fargo | initiate | — → Overweight | $27 | 54% |
| Mar 7, 2023 | Credit Suisse | initiate | — → Outperform | $40 | — |
| Mar 7, 2023 | Guggenheim | initiate | — → Buy | $32 | 52% |
| Mar 7, 2023 | B of A Securities | initiate | — → Buy | $39 | 53% |
| Mar 7, 2023 | Stifel | initiate | — → Buy | $45 | 53% |
Price Target Trend
Jul 7, 2026 Latest: $46.33 Oct 24, 2026
EPS Estimates
0y $-4.43
Lo: $-4.63 Hi: $-3.93
8 analysts +1y $-2.46
Lo: $-3.78 Hi: $-1.20
9 analysts ▲2
+1q $-0.59
Lo: $-0.73 Hi: $-0.45
8 analysts ▲3
0q $-0.54
Lo: $-0.60 Hi: $-0.39
8 analysts ▲4
Cross-Platform Signals
No cross-platform signals in the last 90 days